Clearside Biomedical Inc

NASDAQ:CLSD   9:56:08 AM EDT
2.05
+0.09 (+4.59%)
Other Pre-Announcement

Clearside Biomedical Reports Third Quarter 2020 Financial Results

Published: 11/10/2020 21:29 GMT
Clearside Biomedical Inc (CLSD) - Clearside Biomedical Announces Third Quarter 2020 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.05.
Q3 Earnings per Share Estimate $-0.12 -- Refinitiv Ibes Data (analyst estimates).
Believes It Will Have Sufficient Resources to Fund Its Planned Operations Into Q3 of 2021.
As of September 30, 2020, Clearside's Cash and Cash Equivalents Totaled $14.8 Million.